BIOGEN INC. (BIIB) Return on equity 2016–2025
BIOGEN INC. (BIIB) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
7.1%FY2025 · since FY2016: 30.5% → 7.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 7.1% | -2.7 pp |
| FY2024 | 9.8% | +1.9 pp |
| FY2023 | 7.8% | -14.9 pp |
| FY2022 | 22.7% | +8.5 pp |
| FY2021 | 14.3% | -23.1 pp |
| FY2020 | 37.4% | -6.7 pp |
| FY2019 | 44.1% | +10.2 pp |
| FY2018 | 34.0% | +13.8 pp |
| FY2017 | 20.1% | -10.4 pp |
| FY2016 | 30.5% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice